profits slide at india s dr reddy profits at indian drugmaker dr reddy s fell 93 as research costs rose and sales flagge patents on a number of well known products are due to run out in the near future representing an opportunity for dr reddy whose shares are listed in new york and other indian generics manufacturer the firm said its profits were 40m rupees 915 000 486 000 for the three months to december on sales which fell 8 to 4.7bn rupee research and development of new drugs is continuing apace with r d spending rising 37 to 705m rupees a key cause of the decrease in profits alongside the fall in sale